Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liquid-DRER2: CTC-guided panitumumab in advanced colorectal adenocarcinoma
NCT06314997Phase 2Recruiting
- Sponsor
- Amici di Matteo
- Start
- Jan 2019
- Primary completion
- Dec 2024
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in colorectal adenocarcinoma, sponsored by Amici di Matteo. Started Jan 2019; status: recruiting.
02
Drugs
panitumumab
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on NCT06314997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06314997.